Approval for the use of synthetic peptide antigens esat-6 and cfp-10 and removal of the tuberculin ppd and m. avium ppd antigens used in the quantiferon - tb.  The device, as modified, will be marketed under the trade name quantiferon - tb gold and is indicated for use as an in vitro diagnostic test using peptide cocktails simulating esat-6 and cfp-10 proteins to stimulate cells in heparinized whole blood.  Detection of interferon-y by elisa is used to identify in vitro responses to esat-6 and cfp-10 that are associated with mycobacterium tuberculosis infection.  The device approval is for use of an 8-point calibration curve with manual calculations.